M. Gerber

Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs

M. Kris, M. Ratain, Sunil Sharma, 2007, Clinical Cancer Research.

Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma.

C. Higano, R. Gams, M. Gerber, 1992, Leukemia & lymphoma.

Phase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma.

R. Gams, T. Ervin, D. Hayes, 1990, Cancer research.

Phase I study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762, PNU 152243) administered on a daily x3 schedule.

R. Schilsky, M. Ratain, N. Cooper, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.

A. Bartolucci, R. Weiner, G. Omura, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

S. Swain, C. Vogel, S. Wadler, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.

S. Swain, R. Gams, F. Whaley, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of a phase I study of inhaled doxorubicin combined with docetaxel and cisplatin for advanced non-small cell lung cancer

J. Schiller, G. Otterson, M. Villalona-Calero, 2005 .

Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.

S. Feig, H. Sather, M. Trigg, 1996, Medical and pediatric oncology.